ArticlePharmaceuticals (Basel, Switzerland)2023

Lysicamine Reduces Protein Kinase B (AKT) Activation and Promotes Necrosis in Anaplastic Thyroid Cancer.

Mariana Teixeira Rodrigues et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.